CUMBERLAND PHARMACEUTICALS INC Quarterly Amortization of Intangible Assets in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Cumberland Pharmaceuticals Inc quarterly/annual Amortization of Intangible Assets history and growth rate from Q2 2010 to Q3 2024.
  • Cumberland Pharmaceuticals Inc Amortization of Intangible Assets for the quarter ending September 30, 2024 was $1.08M, a 8.24% decline year-over-year.
  • Cumberland Pharmaceuticals Inc Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $7.83M, a 94.6% increase year-over-year.
  • Cumberland Pharmaceuticals Inc annual Amortization of Intangible Assets for 2023 was $8.1M, a 59.9% increase from 2022.
  • Cumberland Pharmaceuticals Inc annual Amortization of Intangible Assets for 2022 was $5.07M, a 15.9% increase from 2021.
  • Cumberland Pharmaceuticals Inc annual Amortization of Intangible Assets for 2021 was $4.37M, a 1.42% decline from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $7.83M $1.08M -$96.9K -8.24% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $7.92M $1.1M -$58.4K -5.04% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $7.98M $1.11M -$119K -9.71% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $8.1M $4.54M +$4.08M +891% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $4.02M $1.18M -$311K -20.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $4.33M $1.16M -$371K -24.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $4.7M $1.23M -$363K -22.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $5.07M $458K -$559K -55% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $5.63M $1.49M +$473K +46.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $5.15M $1.53M +$358K +30.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $4.8M $1.59M +$424K +36.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $4.37M $1.02M -$132K -11.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-13
Q3 2021 $4.5M $1.01M -$103K -9.23% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $4.61M $1.17M +$79.7K +7.31% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $4.53M $1.17M +$92.9K +8.63% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $4.43M $1.15M +$100K +9.54% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $4.33M $1.12M +$83.3K +8.06% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $4.25M $1.09M +$61.8K +6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $4.19M $1.08M +$54.4K +5.32% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $4.13M $1.05M +$226K +27.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-11
Q3 2019 $3.91M $1.03M +$372K +56.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $3.54M $1.03M +$381K +58.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $3.15M $1.02M +$386K +60.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-22
Q4 2018 $2.77M $823K +$198K +31.8% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-12
Q3 2018 $2.57M $662K +$52.2K +8.57% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $2.52M $649K +$57.9K +9.81% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $2.46M $636K +$24.7K +4.04% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $2.44M $625K +$63.5K +11.3% Oct 1, 2017 Dec 31, 2017 8-K 2020-12-10
Q3 2017 $2.37M $610K +$46.9K +8.33% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $2.33M $591K +$51.1K +9.48% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $2.27M $611K +$80.7K +15.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $2.19M $561K +$43.7K +8.45% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-12
Q3 2016 $2.15M $563K +$89.3K +18.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $2.06M $539K +$27.7K +5.42% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $2.03M $531K +$44K +9.04% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $1.99M $517K +$4.4K +0.86% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-09
Q3 2015 $1.98M $473K -$12.1K -2.48% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $2M $512K +$207K +68.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $1.79M $487K +$193K +65.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 $1.6M $513K +$228K +79.7% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-13
Q3 2014 $1.37M $485K +$283K +139% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $1.09M $304K +$21.6K +7.65% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $1.07M $294K +$169K +135% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 $896K $285K +$151K +112% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-14
Q3 2013 $745K $203K +$74.3K +57.7% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $671K $283K +$151K +115% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 $519K $125K +$13K +11.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $506K $134K -$5.72K -4.08% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-09
Q3 2012 $512K $129K -$43K -25.1% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-06
Q2 2012 $555K $131K -$40.5K -23.6% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $596K $112K -$59.7K -34.8% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $655K $140K Oct 1, 2011 Dec 31, 2011 10-K 2014-03-11
Q3 2011 $172K -$5 0% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-02
Q2 2011 $172K $0 0% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $172K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q3 2010 $172K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 $172K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.